American University of Beirut
Internal Medicine
George Washington University - Internal Medicine
George Washington University - Hematology & Oncology
Clinical / Research Interests
Lung Cancer
Benign and Malignant Blood Disorders

Faysal Haroun, MD is an Assistant Professor of Medicine in the Division of Hematology & Oncology at the GW School of Medicine & Health Sciences. He was awarded his Medical Degree from the American University of Beirut School of Medicine. He completed his Residency in Internal Medicine and Fellowship in Hematology & Oncology at The George Washington University School of Medicine and Health Sciences where he also served as Assistant Chief of Service (Chief Resident).

Dr. Haroun is licensed in the District of Columbia and is a member of several professional organizations, including the American Society of Clinical Oncology, American Society of Hematology and the American Medical Association.

His special interests include lung cancer as well as benign and malignant blood disorders. Dr. Haroun is also invested in novel therapeutics such as immunotherapy and targeted treatments aimed at improving outcomes for our patients.

Dr. Haroun enjoys caring for his patients, and is dedicated to providing the best available therapies to them.

Clinical Trials

Primary objective: to assess the efficacy of concurrent definitive therapy followed by nivolumab compared with concurrent definitive therapy followed by observation in terms of progression-free survival (PFS). (Phase II) II.

Primary Outcome Measure: Maximum tolerated dose of nivolumab [Time Frame: 56 days]
Will be defined as the starting dose level at which 1/6 subjects experience dose limiting toxicity (DLT) with the next higher dose having at least >= 2 participants encountering DLT. Toxicity data will be…